PARIS (dpa-AFX) - Sanofi and its vaccines global business unit Sanofi
Pasteur announced today that the Biomedical Advanced Research and Development
Authority or BARDA within the Office of the Assistant Secretary for Preparedness
and Response in...
PARIS (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNYNF,
SNY) announced Monday that the U.S. Food and Drug Administration has accepted
Dupilumab Biologics License Application or BLA for priority review.
Dupilumab's BLA is...
PARIS (dpa-AFX) - Sanofi (SNYNF, SNY) announced Monday that it filed a
patent infringement suit against Merck Sharp & Dohme Corp. on September 16 in
the United States District Court for the District of Delaware. In its suit
Insulin prices are rising — increases that mean some people are spending as much on monthly diabetes-related expenses as their mortgage payment.
But what makes the rise in insulin prices different than many other old drugs that have drawn...
Insulin has been around since 1923, so it came as a surprise in July 2015 when Cole LePere's doctor told his mother, Janine, to prepare to pay a lot at the pharmacy for it.
Cole, who was 10, had just been found to have Type 1 diabetes, which...
Oops! Unable to complete your request. Please refresh your browser.